Global /United States /Healthcare /Medical Devices /NMTC

NeuroOne Medical Technologies Corp.

NMTC

• NASDAQ: NMTC • Delayed

4.70USD -1.1%

As of 14 June 2026, NeuroOne Medical Technologies Corp. has a market cap of $39.71M USD, ranking #32211 globally and #4613 in the United States. It ranks #2915 in the Healthcare sector, and #605 in the Medical Devices industry.

Global Rank

32211

Country Rank

4613

Sector Rank

2915

Industry Rank

605

Key Stats

Market Cap

$39.71MUSD

Enterprise Value

$36.39MUSD

Revenue (TTM)

$11.72MUSD

EBITDA (TTM)

-$7.38MUSD

Net Income (TTM)

-$6.83MUSD

EBITDA Margin

-63%

Profit Margin

-58%

PS Ratio

3.4

PB Ratio

6.2

Company Profile

Country (HQ)

United States

Sector

Healthcare

Industry

Medical Devices

CEO

David Rosa open_in_new

Employees

Founded

2009

Website

nmtc1.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.1%	-8.9%	4.5%	-15%	-6.1%	1.1%	22%	-50%	-89%

News

NMTC Analyst Forecasts

Markets

Exchange	Ticker	Price	Quotes
NASDAQ MIC: XNAS PRIMARY	NMTC ISIN: US64130M3088 Shares Out.: Shares Outstanding: 8.62M¹ Shares Float: 7.243M² TV: TradingView: NASDAQ: NMTC SA: Stock Analysis: NASDAQ: NMTC YF: Yahoo Finance: NMTC GF: Google Finance: NASDAQ: NMTC NQ: NASDAQ: NMTC BA: Barron's: NMTC MS: Morningstar: XNAS: NMTC	4.70 USD	TV: TradingView: NASDAQ: NMTC SA: Stock Analysis: NASDAQ: NMTC YF: Yahoo Finance: NMTC GF: Google Finance: NASDAQ: NMTC NQ: NASDAQ: NMTC BA: Barron's: NMTC MS: Morningstar: XNAS: NMTC

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About NeuroOne Medical Technologies Corp.

NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other pain-related neurological disorders. The company has a collaboration with the Department of Neurology’s Division of Epilepsy at the University of Minnesota Medical School to advance a study evaluating epilepsy therapies. The company is based in Eden Prairie, Minnesota.

Similar Companies

Industry: Medical Devices (United States)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 436K%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 405K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 400K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 319K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 304K%	38.3	United States
Boston Scientific Corp. NYSE: BSX	$84.93B 214K%	24.5	United States

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Medtronic plc NYSE: MDT	$101.9B 257K%	22.2	Ireland
EssilorLuxottica Société anonyme EPA: EL	$97.46B 84.32B EUR 245K%	36.7	France
HOYA Corp. TSE: 7741	$61.41B 9.83T JPY 155K%	40.0	Japan
Siemens Healthineers AG XETRA: SHL	$45.47B 39.34B EUR 114K%	18.7	Germany
Alcon Inc. SIX: ALC	$36.38B 28.99B CHF 92K%	37.9	Switzerland
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. SHE: 300760	$30.06B 203.66B CNY 76K%	26.0	China

chevron_leftBack